Understanding immune tolerance mechanisms is a major goal of immunology research, but mechanistic studies have generally required the use of mouse models carrying untargeted or targeted antigen receptor transgenes, which distort lymphocyte development and therefore preclude analysis of a truly normal immune system. Here we demonstrate an advance in in vivo analysis of immune tolerance that overcomes these shortcomings. We show that custom superantigens generated by single chain antibody technology permit the study of tolerance in a normal, polyclonal immune system. In the present study we generated a membrane-tethered anti-Igκ–reactive single chain antibody chimeric gene and expressed it as a transgene in mice. B cell tolerance was directly characterized in the transgenic mice and in radiation bone marrow chimeras in which ligand-bearing mice served as recipients of nontransgenic cells. We find that the ubiquitously expressed, Igκ-reactive ligand induces efficient B cell tolerance primarily or exclusively by receptor editing. We also demonstrate the unique advantages of our model in the genetic and cellular analysis of immune tolerance.
Skip Nav Destination
Article navigation
7 March 2005
Article Contents
Article|
February 28 2005
An immunoglobulin Cκ-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system
Djemel Ait-Azzouzene,
Djemel Ait-Azzouzene
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Search for other works by this author on:
Laurent Verkoczy,
Laurent Verkoczy
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Search for other works by this author on:
Jorieke Peters,
Jorieke Peters
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Search for other works by this author on:
Amanda Gavin,
Amanda Gavin
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Search for other works by this author on:
Patrick Skog,
Patrick Skog
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Search for other works by this author on:
José Luis Vela,
José Luis Vela
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
2Kellogg School of Science and Technology Doctoral Program in Chemical and Biological Sciences, The Scripps Research Institute, La Jolla, CA 92037
Search for other works by this author on:
David Nemazee
David Nemazee
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Search for other works by this author on:
Djemel Ait-Azzouzene
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Laurent Verkoczy
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Jorieke Peters
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Amanda Gavin
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
Patrick Skog
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
José Luis Vela
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
2Kellogg School of Science and Technology Doctoral Program in Chemical and Biological Sciences, The Scripps Research Institute, La Jolla, CA 92037
David Nemazee
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
CORRESPONDENCE David Nemazee: [email protected]
Abbreviations used: RAG, recombinase activator gene; RS, recombining sequence.
J. Peters' present address is University Medical Centre, St. Radboud, Nijmegen University, 6500 HB Nijmegen, Netherlands.
Received:
September 08 2004
Accepted:
January 14 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 201 (5): 817–828.
Article history
Received:
September 08 2004
Accepted:
January 14 2005
Citation
Djemel Ait-Azzouzene, Laurent Verkoczy, Jorieke Peters, Amanda Gavin, Patrick Skog, José Luis Vela, David Nemazee; An immunoglobulin Cκ-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system . J Exp Med 7 March 2005; 201 (5): 817–828. doi: https://doi.org/10.1084/jem.20041854
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement